This finding makes the CSF levels of released tau and βA [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42] promising biomarkers for early AD detection [106]. The gene discussed is MAPT; the disease is Alzheimer disease.